Approvals/TGA/ZIRABEV bevacizumab 400 mg/ 16 mL concentrated solution for injection vial

Approved

STANDARD

ZIRABEV bevacizumab 400 mg/ 16 mL concentrated solution for injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 71d307e005fe4495
Product Name: ZIRABEV bevacizumab 400 mg/ 16 mL concentrated solution for injection vial
Artg Id: 309321
Artg Name: ZIRABEV bevacizumab 400 mg/ 16 mL concentrated solution for injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2019-11-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

71d307e005fe4495

Type

Standard